Report Cover

Global Biliary Tumor Market Research Report 2022


Biliary Tumor market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Biliary Tumor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Mecine
    Surgery
    Other
Segment by Application
    Hospitals
    Clinics
    Other
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    NuCana
    NeoGenomics
    Novartis
    GlaxoSmithKline
    Southwest Oncology Group
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biliary Tumor Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Mecine
        1.2.3 Surgery
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Biliary Tumor Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Biliary Tumor Market Perspective (2017-2028)
    2.2 Biliary Tumor Growth Trends by Region
        2.2.1 Biliary Tumor Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Biliary Tumor Historic Market Size by Region (2017-2022)
        2.2.3 Biliary Tumor Forecasted Market Size by Region (2023-2028)
    2.3 Biliary Tumor Market Dynamics
        2.3.1 Biliary Tumor Industry Trends
        2.3.2 Biliary Tumor Market Drivers
        2.3.3 Biliary Tumor Market Challenges
        2.3.4 Biliary Tumor Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Biliary Tumor Players by Revenue
        3.1.1 Global Top Biliary Tumor Players by Revenue (2017-2022)
        3.1.2 Global Biliary Tumor Revenue Market Share by Players (2017-2022)
    3.2 Global Biliary Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biliary Tumor Revenue
    3.4 Global Biliary Tumor Market Concentration Ratio
        3.4.1 Global Biliary Tumor Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biliary Tumor Revenue in 2021
    3.5 Biliary Tumor Key Players Head office and Area Served
    3.6 Key Players Biliary Tumor Product Solution and Service
    3.7 Date of Enter into Biliary Tumor Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Biliary Tumor Breakdown Data by Type
    4.1 Global Biliary Tumor Historic Market Size by Type (2017-2022)
    4.2 Global Biliary Tumor Forecasted Market Size by Type (2023-2028)
5 Biliary Tumor Breakdown Data by Application
    5.1 Global Biliary Tumor Historic Market Size by Application (2017-2022)
    5.2 Global Biliary Tumor Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Biliary Tumor Market Size (2017-2028)
    6.2 North America Biliary Tumor Market Size by Country (2017-2022)
    6.3 North America Biliary Tumor Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Biliary Tumor Market Size (2017-2028)
    7.2 Europe Biliary Tumor Market Size by Country (2017-2022)
    7.3 Europe Biliary Tumor Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Biliary Tumor Market Size (2017-2028)
    8.2 Asia-Pacific Biliary Tumor Market Size by Country (2017-2022)
    8.3 Asia-Pacific Biliary Tumor Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Biliary Tumor Market Size (2017-2028)
    9.2 Latin America Biliary Tumor Market Size by Country (2017-2022)
    9.3 Latin America Biliary Tumor Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Biliary Tumor Market Size (2017-2028)
    10.2 Middle East & Africa Biliary Tumor Market Size by Country (2017-2022)
    10.3 Middle East & Africa Biliary Tumor Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 NuCana
        11.1.1 NuCana Company Detail
        11.1.2 NuCana Business Overview
        11.1.3 NuCana Biliary Tumor Introduction
        11.1.4 NuCana Revenue in Biliary Tumor Business (2017-2022)
        11.1.5 NuCana Recent Development
    11.2 NeoGenomics
        11.2.1 NeoGenomics Company Detail
        11.2.2 NeoGenomics Business Overview
        11.2.3 NeoGenomics Biliary Tumor Introduction
        11.2.4 NeoGenomics Revenue in Biliary Tumor Business (2017-2022)
        11.2.5 NeoGenomics Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Biliary Tumor Introduction
        11.3.4 Novartis Revenue in Biliary Tumor Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Detail
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Biliary Tumor Introduction
        11.4.4 GlaxoSmithKline Revenue in Biliary Tumor Business (2017-2022)
        11.4.5 GlaxoSmithKline Recent Development
    11.5 Southwest Oncology Group
        11.5.1 Southwest Oncology Group Company Detail
        11.5.2 Southwest Oncology Group Business Overview
        11.5.3 Southwest Oncology Group Biliary Tumor Introduction
        11.5.4 Southwest Oncology Group Revenue in Biliary Tumor Business (2017-2022)
        11.5.5 Southwest Oncology Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Biliary Tumor Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Mecine Table 3. Key Players of Surgery Table 4. Key Players of Other Table 5. Global Biliary Tumor Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Biliary Tumor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Biliary Tumor Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Biliary Tumor Market Share by Region (2017-2022) Table 9. Global Biliary Tumor Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Biliary Tumor Market Share by Region (2023-2028) Table 11. Biliary Tumor Market Trends Table 12. Biliary Tumor Market Drivers Table 13. Biliary Tumor Market Challenges Table 14. Biliary Tumor Market Restraints Table 15. Global Biliary Tumor Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Biliary Tumor Market Share by Players (2017-2022) Table 17. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Tumor as of 2021) Table 18. Ranking of Global Top Biliary Tumor Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Biliary Tumor Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Biliary Tumor Product Solution and Service Table 22. Date of Enter into Biliary Tumor Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Biliary Tumor Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Biliary Tumor Revenue Market Share by Type (2017-2022) Table 26. Global Biliary Tumor Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Biliary Tumor Revenue Market Share by Type (2023-2028) Table 28. Global Biliary Tumor Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Biliary Tumor Revenue Market Share by Application (2017-2022) Table 30. Global Biliary Tumor Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Biliary Tumor Revenue Market Share by Application (2023-2028) Table 32. North America Biliary Tumor Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Biliary Tumor Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Biliary Tumor Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Biliary Tumor Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Biliary Tumor Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Biliary Tumor Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Biliary Tumor Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Biliary Tumor Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Biliary Tumor Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Biliary Tumor Market Size by Country (2023-2028) & (US$ Million) Table 42. NuCana Company Detail Table 43. NuCana Business Overview Table 44. NuCana Biliary Tumor Product Table 45. NuCana Revenue in Biliary Tumor Business (2017-2022) & (US$ Million) Table 46. NuCana Recent Development Table 47. NeoGenomics Company Detail Table 48. NeoGenomics Business Overview Table 49. NeoGenomics Biliary Tumor Product Table 50. NeoGenomics Revenue in Biliary Tumor Business (2017-2022) & (US$ Million) Table 51. NeoGenomics Recent Development Table 52. Novartis Company Detail Table 53. Novartis Business Overview Table 54. Novartis Biliary Tumor Product Table 55. Novartis Revenue in Biliary Tumor Business (2017-2022) & (US$ Million) Table 56. Novartis Recent Development Table 57. GlaxoSmithKline Company Detail Table 58. GlaxoSmithKline Business Overview Table 59. GlaxoSmithKline Biliary Tumor Product Table 60. GlaxoSmithKline Revenue in Biliary Tumor Business (2017-2022) & (US$ Million) Table 61. GlaxoSmithKline Recent Development Table 62. Southwest Oncology Group Company Detail Table 63. Southwest Oncology Group Business Overview Table 64. Southwest Oncology Group Biliary Tumor Product Table 65. Southwest Oncology Group Revenue in Biliary Tumor Business (2017-2022) & (US$ Million) Table 66. Southwest Oncology Group Recent Development Table 67. Research Programs/Design for This Report Table 68. Key Data Information from Secondary Sources Table 69. Key Data Information from Primary Sources List of Figures Figure 1. Global Biliary Tumor Market Share by Type: 2021 VS 2028 Figure 2. Mecine Features Figure 3. Surgery Features Figure 4. Other Features Figure 5. Global Biliary Tumor Market Share by Application in 2021 & 2028 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Other Case Studies Figure 9. Biliary Tumor Report Years Considered Figure 10. Global Biliary Tumor Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Biliary Tumor Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Biliary Tumor Market Share by Region: 2021 VS 2028 Figure 13. Global Biliary Tumor Market Share by Players in 2021 Figure 14. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Tumor as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Biliary Tumor Revenue in 2021 Figure 16. North America Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Biliary Tumor Market Share by Country (2017-2028) Figure 18. United States Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Biliary Tumor Market Share by Country (2017-2028) Figure 22. Germany Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Biliary Tumor Market Share by Region (2017-2028) Figure 30. China Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Biliary Tumor Market Share by Country (2017-2028) Figure 38. Mexico Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Biliary Tumor Market Share by Country (2017-2028) Figure 42. Turkey Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Biliary Tumor Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. NuCana Revenue Growth Rate in Biliary Tumor Business (2017-2022) Figure 45. NeoGenomics Revenue Growth Rate in Biliary Tumor Business (2017-2022) Figure 46. Novartis Revenue Growth Rate in Biliary Tumor Business (2017-2022) Figure 47. GlaxoSmithKline Revenue Growth Rate in Biliary Tumor Business (2017-2022) Figure 48. Southwest Oncology Group Revenue Growth Rate in Biliary Tumor Business (2017-2022) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us